Blog

Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations. 

Rudakou UYu EKrohn LRuskey JA, Dauvilliers Y, Spiegelman D, Greenbaum L, Fahn S, Waters CH, Dupré N, Rouleau GA, Hassin-Baer S, Fon EA, Alcalay RN and Gan-Or ZTargeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations. Brain. 2020. PubMedPreprint

Replication assessment of NUS1 variants in Parkinson’s Disease.

Bustos BI, Bandres-Ciga S, Gibbs JR, Krainc D, Mencacci NE, Gan-Or Z and Lubbe SJ. Replication assessment of NUS1 variants in Parkinson’s DiseaseNeurobiology of Aging. 2020. PubMedPreprint

Association study of DNAJC13, UCHL1, HTRA2, GIGYF2 and EIF4G1 with Parkinson’s disease. 

Saini PRudakou UYu ERuskey JAAsayesh F, Laurent SB, Spiegelman D, Fahn S, Waters C, Monchi O, Dauvilliers Y, Dupré N, Greenbaum L, Hassin-Baer S, Espay AJ, Rouleau GA, Alcalay RN, Fon EA, Postuma RB and Gan-Or ZAssociation study of DNAJC13, UCHL1, HTRA2, GIGYF2 and EIF4G1 with Parkinson’s diseaseNeurobiology of Aging. 2020. PubMedPreprint

Lack of evidence for association of UQCRC1 with Parkinson’s disease in Europeans.

Senkevich K, Bandres-Ciga S, Gan-Or Z and Krohn L. Lack of evidence for association of UQCRC1 with Parkinson’s disease in EuropeansNeurobiology of Aging. 2020. PubMedPreprint

Precision Medicine In Parkinson’s Disease Patients With LRRK2 And GBA Risk Variants – Let’s Get Even More Personal

von Linstow CU, Gan-Or Z and Brundin P. Precision Medicine In Parkinson’s Disease Patients With LRRK2 And GBA Risk Variants – Let’s Get Even More PersonalTranslational Neurodegeneration. 2020. 9(1):39. PubMed

Comprehensive analysis of familial parkinsonism genes in rapid eye movement sleep behavior disorder.

Mufti KRudakou UYu ERuskey JAAsayesh F, Laurent SB, Spiegelman D, Arnulf I, Hu MTM, Montplaisir JY, Gagnon JF, Desautels A, Dauvilliers Y, Gigli GL, Valente M, Janes F, Högl B, Stefani A, Holzknecht E, Sonka K, Kemlink D, Oertel W, Janzen A, Plazzi G, Antelmi E, Figorilli M, Puligheddu M, Mollenhauer B, Trenkwalder C, Sixel-Döring F, Cochen De Cock V, Monaca CC, Heidbreder A, Ferini-Strambi L, Dijkstra F, Viaene M, Abril B, Boeve BF, Postuma RB, Rouleau GA and Gan-Or ZComprehensive analysis of familial parkinsonism genes in rapid eye movement sleep behavior disorder. Movement Disorders. 2020. PubMedPreprint

Analysis of heterozygous PRKN variants and copy number variations in Parkinson’s disease.

Yu ERudakov UKrohn L, Mufti K, Ruskey JAAsayesh FEstiar MA, Spiegelman D, Fahn S, Waters CH, Greenbaum L, Espay AJ, Dauvilliers Y, Dupré N, Rouleau GA, Hassin-Baer S, Fon EA, Alcalay RN and Gan-Or ZAnalysis of heterozygous PRKN variants and copy number variations in Parkinson’s disease. Movement Disorders. 2020. PubMedPreprint

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients.

Alcalay RN, Wolf P, Chiang MSR, Helesicova K, Zhang XK, Merchant K, Hutten SJ, Scherzer C, Caspell-Garcia C, Blauwendraat C, Foroud T, Nudelman K, Gan-Or Z, Simuni T, Chahine LM, Levy O, Zheng D, Li G and Sardi SP. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patientsAnnals of Clinical and Translational Neurology. In press. 2020. PubMed

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease

Brown EE, Blauwendraat C, Trinh J, Rizig M, Nalls MA, Leveille ERuskey JA, Jonvik H, Tan MMX, Bandres-Ciga S, Hassin-Baer S, Brockmann K, Hardy J, Singleton AB, Alcalay RN, Gasser T, Grosset D, Williams NM, Pittman A, Gan-Or Z, Fernandez-Santiago R, Brice A, Lesage S, Farrer M, Wood N and Morris HR. Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s diseaseNeurobiology of Aging. 2020. PubMedPreprint

Lack of evidence for genetic association of saposins A, B, C and D with Parkinson’s disease.

Sosero YL, Bandres-Ciga S, Hassin-Baer S, Alcalay RN and Gan-Or ZLack of evidence for genetic association of saposins A, B, C and D with Parkinson’s disease. Brain. 2020. PubMedPreprint